Advances in Alzheimer's and Parkinson's Therapies An AAT-AD/PD™ Focus Meeting 2020 is organized by Kenes Group and will be held from Apr 02 - 05, 2020 at Austria Center, Vienna, Wien, Austria.
The Meeting will present all the latest breakthroughs in treatment, translational R&D, early diagnosis, drug development and clinical trials in Alzheimer’s, Parkinson’s and other related neurological disorders.
A central theme will be to further advance innovative strategies in therapy and prevention, clinical trials and diagnostic markers discussed in the sessions and corridors at AD/PD™ 2019, in order to focus on driving successful collaborations among academia and industry, leading to the development of innovative therapies and ultimately providing for a better future for patients and families affected by neurodegenerative diseases.
Additional details will be posted as soon as they are available.
|Contact No. :||+41 22 908 0488|
September 18, 2019
|Registration Type||Last Date||Price|
|Full Participant Onsite Fee||02 Apr,2020||EUR 900.00|
|Participants from developing countries Onsite Fee||02 Apr,2020||EUR 630.00|
|Trainee (Students/Fellows/Nurses) Onsite Fee||02 Apr,2020||EUR 480.00|
|Registration Type||End Date||Price|
|Full Participant Early Bird Fee||07 Jan,2020||EUR 730.00|
|Full Participant Regular Fee||10 Mar,2020||EUR 830.00|
|Participants from developing countries Early Bird Fee||07 Jan,2020||EUR 480.00|
|Participants from developing countries Regular Fee||10 Mar,2020||EUR 580.00|
|Trainee (Students/Fellows/Nurses) Early Bird Fee||07 Jan,2020||EUR 330.00|
|Trainee (Students/Fellows/Nurses) Regular Fee||10 Mar,2020||EUR 430.00|